Multidisciplinary approach to cancer treatment: A model for breast cancer treatment at the M.D. Anderson Cancer Center

International Journal of Clinical Oncology

Volumn 9, Issue 5, 2004, Pages 356-363

  Kim, Ryungsa ^a   Toge, Tetsuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Breast cancer; M.D. Anderson Cancer Center; Multidisciplinary approach; Team management

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER CENTER; CANCER THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; COST OF ILLNESS; DRUG COST; DRUG SAFETY; HEALTH CARE POLICY; HEALTH PRACTITIONER; HUMAN; JAPAN; MASTECTOMY; MEDICAL EDUCATION; MEDICAL RESEARCH; MOUTH ULCER; MULTIMODALITY CANCER THERAPY; NAUSEA; NURSING STAFF; PATIENT CARE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; VOMITING;

BREAST NEOPLASMS; CANCER CARE FACILITIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERPROFESSIONAL RELATIONS; ORGANIZATIONAL POLICY; PATIENT CARE TEAM; TEXAS;

EID: 10944270624     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0411-7     Document Type: Review

References (20)

1. Benner P (1984) From novice to expert. Addison-Wesley, Menlo Park
2. Bonnie RJ (1997) Research with cognitively impaired subjects. Unfinished business in the regulation of human research. Arch Gen Psychiatry 54:105-111
3. Pusztai L, Ayers M, Stec J, et al. (2003) Clinical application of cDNA microarrays in oncology. Oncologist 8:252-258
4. Hortobagyi GN, Blumenschein GR, Spanos W, et al. (1983) Multimodal treatment of locoregionally advanced breast cancer. Cancer 51:763-768
5. Valero V, Buzdar AU, McNeese M, et al. (2002) Primary chemotherapy in the treatment of breast cancer: the University of Texas M.D. Anderson Cancer Center experience. Clin Breast Cancer 3:863-68
6. Fisher B, Bryant J, Wolmark N, et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
7. Cleator S, Parton M, Dowsett M (2002) The biology of neoadjuvant chemotherapy for breast cancer. Endocr Relat Cancer 9:183-195
8. Kuerer HM, Newman LA, Smith TL, et al. (1999) Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460-469
9. Valero V (2002) Primary chemotherapy with docetaxel for the management of breast cancer. Oncology (Huntingt) 16:35-43
10. Henderson IC, Berry DA, Demetri GD, et al. (2003) Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21:976-983
11. Mamounas EP, Bryant J, Lembersky BC, et al. (2003) Paclitaxel (T) following doxorubicin/cyclophosphamide (AC) as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. Proc Am Soc Clin Oncol 12:4
12. Buzdar AU, Singletary SE, Theriault RL, et al. (1999) Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol 17:3412-3417
13. Buzdar AU, Singletary SE, Valero V, et al. (2002) Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res 8:1073-1079
14. Green M, Hortobagyi GN (2002) Neoadjuvant chemotherapy for operable breast cancer. Oncology (Huntingt) 16:871-884
15. Hortobagyi GN, Frye D, Buzdar AU, et al. (1989) Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma. Cancer 63:37-45
16. Kuerer HM, Singletary SE, Buzdar AU, et al. (2001) Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182: 601-608
17. Breslin TM, Cohen L, Sahin A, et al. (2000) Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18:3480-3486
18. Edeiken BS, Fornage BD, Bedi DG, et al. (1999) US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy. Radiology 213:895-900
19. Buchholz TA, Strom EA, Perkins GH, et al. (2002) Controversies regarding the use of radiation after mastectomy in breast cancer. Oncologist 7:539-546
20. Keisch M, Vicini F, Kuske RR, et al. (2003) Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55:289-293